Page last updated: 2024-09-03
plavix and dipyridamole
plavix has been researched along with dipyridamole in 1 studies
Compound Research Comparison
Studies
(plavix) | Trials
(plavix) | Recent Studies (post-2010)
(plavix) | Studies
(dipyridamole) | Trials
(dipyridamole) | Recent Studies (post-2010) (dipyridamole) |
|---|
| 7 | 0 | 5 | 7,826 | 881 | 632 |
Protein Interaction Comparison
| Protein | Taxonomy | plavix (IC50) | dipyridamole (IC50) |
|---|
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | | 21.0682 |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | | 21.0682 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | | 3.1233 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | | 2.6 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | | 5.15 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | | 2.6333 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | | 1.9708 |
| 3',5'-cyclic-AMP phosphodiesterase | Sus scrofa (pig) | | 5.835 |
| Bile salt export pump | Homo sapiens (human) | | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | | 6.956 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | | 0.5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | | 0.5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | | 0.5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | | 2.1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | | 2.6333 |
| Exopolyphosphatase PRUNE1 | Homo sapiens (human) | | 0.78 |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | | 0.0537 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | | 6.4 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Other Studies
1 other study(ies) available for plavix and dipyridamole
| Article | Year |
|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |